Skip to content

Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery

Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03676114
Enrollment
100
Registered
2018-09-18
Start date
2018-09-20
Completion date
2020-02-29
Last updated
2018-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Ketamine, Breast Cancer Surgery, Postoperative Recovery

Brief summary

Breast cancer patients often have perioperative emotional disorders such as anxiety and depression, which can lead to poor quality of recovery.This study aims to determine whether ketamine could improve the quality of recovery in breast cancer patients. Meanwhile, it will show if ketamine could improve anxiety, depression, postoperative pain and fatigue.This trial also will bring great concerns on patients' mental health perioperatively and explore the measures to improve their quality of life.

Interventions

DRUGketamine

0.5mg/kg intravenous ketamine injection before incision followed by 0.25mg/kg/hr intravenous ketamine infusion during the operation

DRUGNormal saline

Same volume of normal saline will be administrated

Sponsors

Han Yuan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. American Society of Anesthesiologists Grade I-II 2. Patients undergoing elective breast cancer surgery under general anesthesia

Exclusion criteria

1. Unstable hypertension, history of heart disease 2. Hepatic or renal dysfunction 3. Patients undergoing chemotherapy before surgery 4. Have a history of chronic pain or chronic use of analgesic 5. Have mental illness or can't cooperate with investigators 6. Have a history of ketamine allergy

Design outcomes

Primary

MeasureTime frameDescription
QoR40 scorethe first day after surgeryQuality of recovery will be evaluated by Quality of Recovery 40 (QoR40),which assesses five dimensions of recovery (physical comfort,emotional state, physical independence , physiological support and pain ). Each item is rated on a five-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR40 ranges from 40 (poorest quality of recovery) to 200 (best quality of recovery).

Secondary

MeasureTime frameDescription
ICFS scoresPostoperative 3 days, 7 days and 30 daysFatigue state will be evaluated by Identity Consequence Fatigue Scale (ICFS).ICFS is based on a score of 31-173, higher scores representing worse state of fatigue.
HADS scoresPostoperative 2 days and 3monthsPerioperative emotion will be evaluated by the hospital anxiety and depression scale(HADS).The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.
Chronic Pain3 months after surgeryThe incidence of chronic pain at 3 months after surgery
NRS pain scoresat 4 hours, 24 hours, and 48 hours after surgeryEvaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
Postoperative complicationsPostoperative 1 day, 2 days and 3 dayshallucination, nightmare and delirium will be recorded

Countries

China

Contacts

Primary ContactJunli Cao
caojl0310@yahoo.com.cn+86 15162160809
Backup ContactYuan Han
hanyuan-trial@163.com+86 13852470693

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026